Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
354 studies found for:    Shingles
Show Display Options
Rank Status Study
21 Completed Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Conditions: Herpes Zoster;   Herpes Zoster Vaccine
Interventions: Biological: Herpes zoster vaccine GSK1437173A;   Biological: Placebo
22 Completed
Has Results
A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)
Condition: Herpes Zoster
Interventions: Biological: zoster vaccine live (ZOSTAVAX™);   Biological: Comparator: Placebo
23 Completed Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)
Condition: Shingles
Interventions: Biological: zoster vaccine live (Oka/Merck);   Biological: Comparator: placebo (unspecified)
24 Recruiting Immune Response to Shingles Vaccination
Condition: Shingles
Intervention: Drug: Zoster Vaccine Live
25 Recruiting Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
26 Completed Herpes Zoster Prevalence in Frailty Consultations
Condition: Herpes Zoster
Intervention: Other: Medical Questionary
27 Completed
Has Results
Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles
Conditions: Virus Diseases;   Herpes Zoster
Intervention:
28 Completed Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK 1437173A
29 Completed VZV PCR Sampling Validation Study
Condition: Herpes Zoster
Interventions: Procedure: Herpes zoster sampling procedure for VZV PCR;   Procedure: Blood sampling
30 Completed
Has Results
Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)
Condition: Shingles
Interventions: Biological: Zoster Vaccine, Live (Zostavax™);   Biological: Comparator: Placebo
31 Completed
Has Results
ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: Zoster Vaccine Live
32 Completed
Has Results
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Conditions: Herpes Zoster;   HIV Infections
Interventions: Biological: ZOSTAVAX;   Biological: Placebo
33 Completed Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster vaccine (GSK 1437173A)
34 Completed
Has Results
Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: Zoster Vaccine Live
35 Completed Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster vaccine (GSK1437173A)
36 Completed Immune Response to Varicella-Zoster Vaccination and Infection
Conditions: Chickenpox;   Herpes Zoster
Intervention:
37 Active, not recruiting Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster vaccine GSK1437173A;   Biological: Placebo
38 Completed Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine 1437173A;   Biological: Placebo
39 Recruiting Herpes Zoster Vaccine for Bone Marrow Transplant Donors
Condition: Herpes Zoster
Intervention: Biological: Zostavax
40 Completed Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine When Administered Under the Skin (Subcutaneously) vs. Into a Muscle (Intramuscularly) in Adults 50 Years of Age and Older
Condition: Herpes Zoster
Intervention: Biological: Herpes zoster vaccine GSK1437173A

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years